ODAPRA, created in 2011 (United States), from
126 sister brands
and 17479 competing brands.
The ODAPRA brand is owned by Celgene, a company listed in New York.
ODAPRA is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.